Galantamine

Results: 49



#Item
11Volume[removed]Senior Editor: Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Junior Editor: Karen L.A. Wlock, B.Sc.(Pharm.) This edition edited by: B. Cadario

Volume[removed]Senior Editor: Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Junior Editor: Karen L.A. Wlock, B.Sc.(Pharm.) This edition edited by: B. Cadario

Add to Reading List

Source URL: dpic.org

Language: English - Date: 2014-11-10 15:46:27
12Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2014-11-20 01:17:33
13Published by Ministry of Health, Labour and Welfare Translated by Pharmaceuticals and Medical Devices Agency

Published by Ministry of Health, Labour and Welfare Translated by Pharmaceuticals and Medical Devices Agency

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2014-11-20 01:17:33
14Guidelines Guidelines & Protocols & Protocols Advisory Advisory

Guidelines Guidelines & Protocols & Protocols Advisory Advisory

Add to Reading List

Source URL: www.bcguidelines.ca

Language: English - Date: 2014-09-23 17:41:54
15Updates to the Alberta Human Services Drug Benefit Supplement Effective November 1, 2014  Inquiries should be directed to:

Updates to the Alberta Human Services Drug Benefit Supplement Effective November 1, 2014 Inquiries should be directed to:

Add to Reading List

Source URL: www.ab.bluecross.ca

Language: English - Date: 2014-11-24 17:45:45
16Updates to the Alberta Human Services Drug Benefit Supplement Effective August 1, 2014  Inquiries should be directed to:

Updates to the Alberta Human Services Drug Benefit Supplement Effective August 1, 2014 Inquiries should be directed to:

Add to Reading List

Source URL: www.ab.bluecross.ca

Language: English - Date: 2014-07-25 18:04:21
17Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Add to Reading List

Source URL: www.health.gov.on.ca

Language: English - Date: 2014-09-17 13:39:55
18Alzheimer’s Disease Medications FA C T S H E E T S  everal prescription drugs are

Alzheimer’s Disease Medications FA C T S H E E T S everal prescription drugs are

Add to Reading List

Source URL: www.nia.nih.gov

Language: English - Date: 2014-02-12 09:40:42
19NOVA SCOTIA PROVINCIAL PHARMACARE PROGRAMS Request for Renewal of a Cholinesterase Inhibitor Please provide the following to support your request for renewal of a cholinesterase inhibitor PATIENT INFORMATION PATIENT SURN

NOVA SCOTIA PROVINCIAL PHARMACARE PROGRAMS Request for Renewal of a Cholinesterase Inhibitor Please provide the following to support your request for renewal of a cholinesterase inhibitor PATIENT INFORMATION PATIENT SURN

Add to Reading List

Source URL: novascotia.ca

Language: English - Date: 2013-10-09 13:42:26
20HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NAMENDA safely and effectively. See full prescribing information for NAMENDA.  ------------------------CONTRAINDICAT

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NAMENDA safely and effectively. See full prescribing information for NAMENDA. ------------------------CONTRAINDICAT

Add to Reading List

Source URL: www.frx.com

Language: English